# The Isthmus Logic Post Market Clinical Follow-up Study

> **NCT05616143** · — · UNKNOWN · sponsor: **CID S.p.A.** · enrollment: 80 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** Isthmus Logic

## Key facts

- **NCT ID:** NCT05616143
- **Lead sponsor:** CID S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-02
- **Primary completion:** 2023-06
- **Final completion:** 2023-07
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2022-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05616143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05616143, "The Isthmus Logic Post Market Clinical Follow-up Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05616143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*